Academic Myeloma Consortium-Core Solutions: 10-MM-01: A Multi-Center Phase I/II, Open-Label, Dose-Finding Pilot Study of the Combination of Carfilzomib and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Hackensack

Sponsor
AMyC-Core Solutions-10-MM-01

Protocol Number
AMyC-Core Solutions-10-MM-01

To Learn More Call
201-510-0910